MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
出版年份 2014 全文链接
标题
MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 12, Pages e114419
出版商
Public Library of Science (PLoS)
发表日期
2014-12-23
DOI
10.1371/journal.pone.0114419
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
- (2014) Shoji Yamamoto et al. CANCER CELL
- Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer
- (2013) Jayalakshmi Sridhar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
- (2013) H. Okuda et al. CANCER RESEARCH
- Control of metastatic progression by microRNA regulatory networks
- (2013) Nora Pencheva et al. NATURE CELL BIOLOGY
- MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3
- (2013) Noelia Sanchez et al. PLoS One
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression
- (2012) Xiangjun Kong et al. PLoS One
- Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e
- (2011) Doyel Mitra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
- (2010) Lu Jiang et al. BIOCHEMICAL JOURNAL
- Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
- (2010) Diana M. Cittelly et al. CARCINOGENESIS
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
- (2009) D. Mitra et al. MOLECULAR CANCER THERAPEUTICS
- The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
- (2008) A. Naresh et al. CANCER RESEARCH
- microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma
- (2008) B. Kefas et al. CANCER RESEARCH
- MicroRNA-7, a Homeobox D10 Target, Inhibits p21-Activated Kinase 1 and Regulates Its Functions
- (2008) S. D. N. Reddy et al. CANCER RESEARCH
- Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
- (2008) Rebecca J. Webster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small is beautiful: microRNAs and breast cancer-where are we now?
- (2008) ET Verghese et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search